FR EA

Matter 1046-00001 — Helix Bio Therapeutics Inc

2023 · 12 documents · M&A / Corporate · S. Beaumont

23.3hours logged
$4,800unbilled WIP
$19,700billed to date
DateLawyerDescription HoursAmount
2025-10-31 C. Fontaine Correspondence re closing checklist 2.6 $2,730
2025-11-04 R. Okafor Legal research re funds flow memorandum 4.4 $4,620
2025-11-08 S. Beaumont Correspondence re legal opinion hbt counsel 2.0 $2,100
2025-11-18 C. Fontaine Draft and revise closing email to client 3.6 $3,780
2025-12-06 D. Lindqvist Legal research re due diligence memo hbt 3.2 $3,360
2025-11-30 R. Okafor Analyze structuring and tax memo 2.8 $2,940
2025-12-06 S. Beaumont Legal research re engagement letter hbt 2.5 $2,625
2025-12-19 J. Whitfield Analyze sec comment response letter 1.7 $1,785
2025-12-02 M. Sage Review and annotate bca redline draft to execution 0.5 $525
2026-01-02 R. Okafor Review and annotate business combination agreement execution 0 $0
2025-12-20 M. Sage Review and annotate pipe subscription agreement crestview 0 $0
2025-12-03 S. Beaumont Draft and revise sponsor support agreement 0 $0
Invoice preview 23.3 $4,800